In 2023, Brian S. Tyler earned $56.26M in total compensation at McKesson, including $1.49M salary and $53.90M in stock. Most recently sold 3,753 shares in Sep 2024. Currently holds stock worth $24.48M. Has donated $18.98M in stock to charitable causes. 6+ years at the helm of McKesson.
Compensation History
Annual executive compensation data for Brian S. Tyler, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$56.26M
Salary
$1.49M
Bonus
$0.00
Other
$864.73K
Salary
$1.49MBoard Justification
The compensation philosophy is designed to attract, retain, and incentivize management while aligning pay with performance, driving long-term value creation, and reflecting shareholder views.
Bonus
$0.00Board Justification
No cash bonus was awarded for FY 2024.
Other Compensation
$864.73KBoard Justification
Other compensation includes 401(k) match, nonqualified deferred compensation plan match, financial counseling, executive security policy costs, and other perquisites.
Restricted Stock
Board Justification
The stock awards that vested in 2024 include 13,736 RSUs and 72,026 PSUs, which were earned based on performance metrics over the three-year period ending March 31, 2024.
Performance Metrics
The performance metrics for FY 2024 included Adjusted EPS, Adjusted Operating Profit, Free Cash Flow, and sustainability priorities.
Brian S. Tyler
CEO of McKesson
Education
N/A
Field of Expertise
Business & Management
Sector of Economy
Healthcare
Born
January 1, 1967 - 58 years ago
CEO of McKesson for
6 years 8 months (Apr 2019 - Present)
Previous Experience
Chairman of the Management Board of McKesson Europe AG, President of North American Pharmaceutical Distribution and Services
Other McKesson CEOs
Holdings
Track Brian S. Tyler's stock holdings and portfolio value over time.
Total Stock Sold
$118.57M
$118.57M
330,929 MCK shares
What if they kept their stock?
If Brian S. Tyler didn't sell their stock, today they would have:
Extra MCK330,929 shares worth $269.44M.
This is 127.24% and $150.87M more than what they got when they sold the stock.
Charitable Transactions
23,307 shares
MCK
Recent Charitable Transactions
3,600 shares
MCK
May 30, 2024
Charity
1,282 shares
MCK
Jun 5, 2023
Charity
18,425 shares
MCK
Apr 18, 2022
Charity
Insider Trading
Brian S. Tyler's recent stock transactions, purchases, and sales filed with the SEC.
$2.11M
MCK at $561.10/share
Sep 5, 2024
Sale
$2.35M
MCK at $626.03/share
Aug 5, 2024
Sale
$2.18M
MCK at $580.92/share
Jul 3, 2024
Sale
$2.16M
MCK at $574.41/share
Jun 5, 2024
Sale
3,600 shares
MCK
May 30, 2024
Charity
72,026 shares
MCK
May 21, 2024
Received
$1.82M
MCK at $524.55/share
Mar 15, 2024
Sale
$6.73M
MCK at $480.00/share
Jan 3, 2024
Sale
Rivals
Compare Brian S. Tyler with competitor CEOs and industry peers.
Joseph W. Dziedzic
CEO of Integer Holdings
2022 Compensation
Stock
$0.00
Salary
$1.23M
Bonus
$0.00
Other
$97.75K
Total Holdings
$77.20M
James C. Foster
CEO of Charles River Laboratories
2023 Compensation
Stock
$0.00
Salary
$1.48M
Bonus
$1.13M
Other
$71.89K
Total Holdings
$582.93K
Eric M. Green
CEO of West Pharmaceutical Services
2023 Compensation
Stock
$0.00
Salary
$1.14M
Bonus
$1.67M
Other
$92.48K
Total Holdings
$159.06M
Stanley M. Bergman
CEO of Henry Schein
2023 Compensation
Stock
$0.00
Salary
$1.63M
Bonus
$643.65K
Other
$341.74K
Total Holdings
$49.43M
Fred P. Lampropoulos
Founder and CEO of Merit Medical Systems
2023 Compensation
Stock
$2.77M
Salary
$1.89M
Bonus
$1.34M
Other
$8.70K
Total Holdings
$38.99M